Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,976 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01847235 | Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial | completed | Phase 2 | 23 | Seoul National University HospitalOTHER | 1 | Apr 26, 2016 | clinicaltrials |
| NCT01925118 | Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2 | terminated | Phase 2 | 9 | Seoul National University HospitalOTHER | 1 | Apr 26, 2016 | clinicaltrials |
| NCT01137097 | Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC(LSLNB) | completed | Phase 2 / Phase 3 | 278 | Samsung Medical CenterOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT01149161 | Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma | unknown | Phase 2 / Phase 3 | 2,000 | Samsung Medical CenterOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT01312324 | Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer | completed | Phase 2 | 27 | Samsung Medical CenterOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02250872 | Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury | unknown | Phase 2 / Phase 3 | 182 | Seoul National University Bundang HospitalOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02572050 | Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection(AaRon) | unknown | Phase 2 | 87 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02745483 | Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study | completed | Phase 2 | 153 | Seoul National University HospitalOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02195089 | Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) | completed | Phase 1 / Phase 2 | 19 | BioLeaders CorporationINDUSTRY | 1 | Apr 19, 2016 | clinicaltrials |
| NCT01130805 | A Study of Pazopanib With CAPEOX in AGC Patients | completed | Phase 2 | 66 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01578343 | Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma(ZOLINZA) | terminated | Phase 2 | 20 | Samsung Medical CenterOTHER | 1 | Apr 15, 2016 | clinicaltrials |
| NCT01213095 | Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL) | completed | Phase 2 | 48 | Dong-A University HospitalOTHER | 1 | Apr 11, 2016 | clinicaltrials |
| NCT02732483 | Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding | unknown | Phase 2 | 32 | Yonsei UniversityOTHER | 1 | Apr 8, 2016 | clinicaltrials |
| NCT02683538 | Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies | completed | Phase 2 | 196 | Seoul National University HospitalOTHER | 1 | Apr 5, 2016 | clinicaltrials |
| NCT00987935 | A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients | completed | Phase 2 | 134 | Boehringer IngelheimINDUSTRY | 2 | Mar 10, 2016 | clinicaltrials |
| NCT01746771 | A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 44 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Mar 3, 2016 | clinicaltrials |
| NCT01124864 | A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. | completed | Phase 2 | 153 | Novartis PharmaceuticalsINDUSTRY | 10 | Mar 2, 2016 | clinicaltrials |
| NCT01819428 | NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma | terminated | Phase 2 | 22 | National OncoVentureOTHER | 1 | Mar 1, 2016 | clinicaltrials |
| NCT01961583 | [18F]Fluciclatide PET Imaging of Pazopanib Response | terminated | Phase 2 | 12 | Asan Medical CenterOTHER | 1 | Mar 1, 2016 | clinicaltrials |
| NCT00347919 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer | completed | Phase 2 | 189 | GlaxoSmithKlineINDUSTRY | 16 | Feb 25, 2016 | clinicaltrials |
| NCT00455533 | Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer | completed | Phase 2 | 384 | Bristol-Myers SquibbINDUSTRY | 15 | Feb 24, 2016 | clinicaltrials |
| NCT00336843 | Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma | completed | Phase 2 | 19 | Asan Medical CenterOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00337259 | Gemcitabine for Marginal Zone Lymphoma | terminated | Phase 2 | 43 | Asan Medical CenterOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT01783834 | Gefitinib Versus Pemetrexed for Previously Treated NSCLC Patients | completed | Phase 2 | 95 | Gachon University Gil Medical CenterOTHER | 1 | Feb 11, 2016 | clinicaltrials |
| NCT01784107 | A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01784120 | A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer | unknown | Phase 2 | 48 | Gachon University Gil Medical CenterOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT02200315 | No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy(KSWEET-01) | completed | Phase 2 | 98 | Korean South West East Gastric Surgery GroupOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01653496 | Compliance to ERAS After Gastric Surgery(ERAS) | completed | Phase 2 | 168 | Chonnam National University HospitalOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT00526669 | Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib | completed | Phase 2 | 68 | GlaxoSmithKlineINDUSTRY | 6 | Jan 29, 2016 | clinicaltrials |
| NCT01826045 | Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia(PGA) | completed | Phase 2 | 200 | BioLeaders CorporationINDUSTRY | 1 | Jan 29, 2016 | clinicaltrials |
| NCT00982488 | Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia(START rollover) | completed | Phase 2 | 238 | Bristol-Myers SquibbINDUSTRY | 24 | Jan 22, 2016 | clinicaltrials |
| NCT00712790 | Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 35 | Singapore Clinical Research InstituteOTHER | 4 | Jan 6, 2016 | clinicaltrials |
| NCT00731328 | Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome | completed | Phase 2 | 15 | Asan Medical CenterOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT01020734 | Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | completed | Phase 2 | 263 | Asan Medical CenterOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT01795378 | Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation(DNKI-II) | completed | Phase 1 / Phase 2 | 56 | Asan Medical CenterOTHER | 1 | Dec 31, 2015 | clinicaltrials |
| NCT01099514 | Study of Nilotinib in Metastatic Melanoma With KIT Aberrations | completed | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01099527 | A Trial of RAD001/Capecitabine in Refractory Gastric Cancer | completed | Phase 1 / Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01099540 | Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor | completed | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01469598 | Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01474642 | Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 64 | Samsung Medical CenterOTHER | 1 | Dec 29, 2015 | clinicaltrials |
| NCT01263886 | Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer(DISRUPT) | completed | Phase 2 | 176 | SanofiINDUSTRY | 13 | Dec 21, 2015 | clinicaltrials |
| NCT00389155 | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy | completed | Phase 2 / Phase 3 | 34 | Bristol-Myers SquibbINDUSTRY | 16 | Dec 7, 2015 | clinicaltrials |
| NCT01232296 | A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment | completed | Phase 2 | 162 | Novartis PharmaceuticalsINDUSTRY | 7 | Dec 4, 2015 | clinicaltrials |
| NCT02008929 | to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)(MG4101) | completed | Phase 2 | 5 | Samsung Medical CenterOTHER | 1 | Dec 3, 2015 | clinicaltrials |
| NCT01152853 | PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer(PF299804-AGC) | completed | Phase 2 | 28 | Seoul National University HospitalOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02558387 | Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck | unknown | Phase 2 | 20 | Samsung Medical CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT02347956 | The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer | completed | Phase 1 / Phase 2 | 19 | Yonsei UniversityOTHER | 1 | Nov 16, 2015 | clinicaltrials |
| NCT01159327 | Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy | terminated | Phase 2 | 13 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 11, 2015 | clinicaltrials |
| NCT01677455 | An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer(Enchant) | completed | Phase 2 | 51 | Synta Pharmaceuticals Corp.INDUSTRY | 8 | Nov 5, 2015 | clinicaltrials |
| NCT00594984 | Phase I/II Combination With Irinotecan- Erbitux | completed | Phase 1 / Phase 2 | 38 | Bristol-Myers SquibbINDUSTRY | 7 | Nov 4, 2015 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials